About St Pancras
Clinical Research
Adding value through partnership
Delivering Clinical Trials
St Pancras Clinical Research are experts in setting up, recruiting for and coordinating phase 1b – III clinical trials from start-up to completion.
We work in partnership with pharmaceutical companies locally and globally to deliver clinical trials on time and to budget.
SPCR has a reputation for excellence in all that we do with both participants and pharmaceutical companies.
Therapeutic Focus Ib - III trials
St Pancras Clinical Research understands the challenges faced by the industry and prides itself on working with our partners to deliver cost-effective and professional solutions in creative and adaptive ways.
We understand the drug development cycle and work towards timely contract negotiations and regulatory approvals, with significantly shorter study set-up periods in comparison with UK public sector sites.
Our varied participant recruitment strategies enable us to comprehensively pre-screen potential participants to maintain a high screening to randomisation ratio for sponsors.
Centralising research in the City of London
We specialise in conditions with an unmet medical need. Our experience includes chronic pain and memory disorders resulting from inflammatory, neurological and neurodegenerative conditions, as well as for patients with diabetes, rare diseases, and neuropsychiatric conditions.
Since welcoming our first participants in 2017, we have delivered over 45 complex clinical trials successfully, providing a valuable service to the individuals who need it most across the UK.
Unrivalled patient recruitment potential.
Easily accessible London clinic.
Connections to world class healthcare institutions.
We are located in the City of London within easy access of major transport hubs giving us unrivalled access to a wide and diverse population across Greater London and beyond.
Our location and networks provide access to an exceptional range of links to secondary health care providers in London hospitals and world class research institutions.
The St Pancras Senior Management Team
David James
Non-Executive Chairman
30+ years spent in international investment banking. Broad range of experience advising major corporations and boards.
Currently Joint Head of UK Investment Banking at UBS. Previously, Vice Chairman of Europe Middle East Africa Banking at Citigroup. David graduated from Cambridge University with a Masters degree.
Sandie James
Chief Executive Officer
Over 12 years in Banking and International Finance for Blue Chip finance houses including SG Warburg & Kleinwort Benson. Headed up financial regulatory risk department. Director of James Beaufort Ltd.
Sandie is a joint founder of the company and the Chief Executive Officer.
Dr Stuart Ratcliffe
Chief Scientific Officer
35+ years' experience in clinical research phases I-IV. Conducted over 200 clinical trials as Principal, Chief and Coordinating Investigator.
Developed and led trial programmes in the public (NHS), academic (QMUL), pharmaceutical and private sectors.
Dorothy Harris
Head of Governance and Strategic Communications
30+ years experience in consulting and management in a range of industries globally, from start-ups to multinationals, specialising in risk management, communications and governance.
MSc in Environmental Management from Imperial College and a Postgraduate Diploma in Cross-Sector Partnership from the University of Cambridge.
Rajal Nott
Head of Clinical Operations
Beth Bond
Head of Business Operations
Kitty James
Head of HR and Health and Safety